Chemours vs Ingevity
Chemours spun out of DuPont carrying both high-value fluoroproducts businesses and legacy environmental liabilities that continue to weigh on its balance sheet, while Ingevity extracts specialty chemicals from crude tall oil and activated carbon products that serve a narrower but highly defensible set of markets. Both are specialty chemical companies where product mix and liability management define the investment case. The Chemours vs Ingevity comparison examines free cash flow generation, litigation risk, leverage, and which company's operational profile offers the cleaner path to shareholder returns.
Chemours spun out of DuPont carrying both high-value fluoroproducts businesses and legacy environmental liabilities that continue to weigh on its balance sheet, while Ingevity extracts specialty chemi...
Investment Analysis
Chemours
CC
Pros
- Strong demand for Opteon™ refrigerant products supports operational performance despite challenging macroeconomic conditions.
- Attractive valuation with discount cash flow analysis suggesting the stock is undervalued by approximately 33%, offering potential value for long-term investors.
- Analyst consensus rates Chemours as a 'Buy' with an average price target implying a potential 35% upside from current levels.
Considerations
- Q3 2025 earnings significantly missed estimates, with EPS of $0.20 versus $0.26 expected, highlighting near-term profitability challenges.
- Ongoing environmental litigation and leadership changes introduce uncertainty and have contributed to a 40% stock decline over the past year.
- Net income remains negative with reported losses, reflecting continued operational and financial headwinds despite revenue generation.
Ingevity
NGVT
Pros
- Diverse operations spanning specialty chemicals, advanced polymer technologies, and automotive carbon products provide multiple growth avenues.
- Primary revenue generation from North America markets supports operational stability in a large and developed economy.
- Solid balance sheet metrics including a current ratio of 2.00 indicate good short-term liquidity management.
Considerations
- Relatively low quick ratio of 0.69 signals potential challenges in meeting immediate liabilities without inventory sales.
- Negative interest coverage ratio suggests challenges in covering interest expenses, indicating leveraged financial structure.
- Smaller market capitalization and valuation multiples reflect limited scale and potential growth constraints compared to larger peers.
Related Market Insights
Chemical Sector Shake-Up: Riding Berkshire's Ripple
Berkshire Hathaway's $10B OxyChem bid signals confidence in the chemical sector. Discover investment opportunities & ripple effects. Invest commission-free with Nemo.
Aimee Silverwood | Financial Analyst
October 1, 2025
The Unglamorous Giants: Why Society's Necessary Evils Make Compelling Investments
These companies handle society's dirty work—waste management, hazardous chemicals, and industrial cleanup—creating defensive investment opportunities with inelastic demand and regulatory moats.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
Chemical Sector Shake-Up: Riding Berkshire's Ripple
Berkshire Hathaway's $10B OxyChem bid signals confidence in the chemical sector. Discover investment opportunities & ripple effects. Invest commission-free with Nemo.
Aimee Silverwood | Financial Analyst
October 1, 2025
The Unglamorous Giants: Why Society's Necessary Evils Make Compelling Investments
These companies handle society's dirty work—waste management, hazardous chemicals, and industrial cleanup—creating defensive investment opportunities with inelastic demand and regulatory moats.
Aimee Silverwood | Financial Analyst
July 25, 2025
Which Baskets Do They Appear In?
Chemical Sector: Berkshire's $10B Acquisition Impact
Berkshire Hathaway's potential $10 billion acquisition of Occidental's OxyChem unit signals a major investment in the industrial chemical sector. This move could create ripple effects, presenting opportunities for other chemical manufacturers who stand to gain from shifts in the market.
Published: October 1, 2025
Explore BasketNecessary Evils Portfolio
These companies provide the essential infrastructure and services our society can't function without, even if they're not always popular. Carefully selected by our analysts, these stocks offer defensive stability thanks to their non-negotiable role in the global economy.
Published: June 17, 2025
Explore BasketWhich Baskets Do They Appear In?
Chemical Sector: Berkshire's $10B Acquisition Impact
Berkshire Hathaway's potential $10 billion acquisition of Occidental's OxyChem unit signals a major investment in the industrial chemical sector. This move could create ripple effects, presenting opportunities for other chemical manufacturers who stand to gain from shifts in the market.
Published: October 1, 2025
Explore BasketNecessary Evils Portfolio
These companies provide the essential infrastructure and services our society can't function without, even if they're not always popular. Carefully selected by our analysts, these stocks offer defensive stability thanks to their non-negotiable role in the global economy.
Published: June 17, 2025
Explore BasketBuy CC or NGVT in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Chemours vs Ramaco Resources
Chemours makes titanium technologies, thermal and specialty solutions, and advanced performance materials born out of DuPont's chemical legacy, while Ramaco Resources mines metallurgical coal in Appalachia for steel producers. Both companies feed industrial supply chains but operate in markets with very different pricing dynamics and ESG headwinds. The Chemours vs Ramaco Resources comparison explores how a specialty chemical company managing PFAS litigation compares to a coal miner riding a tight met coal market with growing rare earth optionality.
Chemours vs FMC
Chemours manufactures titanium dioxide, refrigerants, and advanced performance chemicals with significant exposure to industrial and construction end markets, while FMC develops crop protection chemicals and biologicals for global agricultural customers. Both are specialty chemical companies managing raw material costs, regulatory pressure, and global pricing dynamics, but they serve very different end markets. Chemours vs FMC compares an industrial and fluorochemicals heavyweight against an agricultural chemistry innovator as each navigates its own version of a challenging global chemicals market.
Ashland vs Ingevity
Ashland is a specialty chemicals company divesting commodity exposure and repositioning around high-value additives for pharma, personal care, and coatings, while Ingevity carves out performance chemicals and activated carbon products from pine-based feedstocks. Both businesses are proving that focused specialty chemistry can command pricing power even as broader industrial demand cycles. Ashland vs Ingevity investigates which portfolio transformation has built the more defensible niche and which margin profile sustains itself through the next demand trough.
